Nutraceuticals Market

Table of Content

1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions

2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis

2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources

2.4.2. Primary Research
2.4.2.1. Introduction

2.4.2.2. Types
2.4.2.2.1. Qualitative
2.4.2.2.2. Quantitative

2.4.2.3. Advantages

2.4.2.4. Techniques
2.4.2.4.1. Interviews
2.4.2.4.2. Surveys
2.4.2.4.3. Focus Groups
2.4.2.4.4. Observational Research
2.4.2.4.5. Social Media Interactions

2.4.2.5. Stakeholders
2.4.2.5.1. Company Executives (CXOs)
2.4.2.5.2. Board of Directors
2.4.2.5.3. Company Presidents and Vice Presidents
2.4.2.5.4. Key Opinion Leaders
2.4.2.5.5. Research and Development Heads
2.4.2.5.6. Technical Experts
2.4.2.5.7. Subject Matter Experts
2.4.2.5.8. Scientists
2.4.2.5.9. Doctors and Other Hospitals

2.4.2.6. Ethics and Integrity
2.4.2.6.1. Research Ethics
2.4.2.6.2. Data Integrity

2.4.3. Analytical Tools and Databases

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach

3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)

3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis

3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation

3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations

4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market

4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario

4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics

5. EXECUTIVE SUMMARY

6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Nutraceuticals
6.2.1. Key Characteristics of Nutraceuticals
6.2.2. Key Applications of the Nutraceuticals
6.2.3. Challenges Associated with Nutraceuticals

6.3. Future Perspective

7. COMPETITIVE LANDSCAPE
7.1. Chapter Overview
7.2. Nutraceutical Developers: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Location of Headquarters

7.2.4. Nutraceuticals: Overall Market Landscape
7.2.4.1. Analysis by Product Type
7.2.4.2. Analysis by Form Type
7.2.4.3. Analysis by Ingredient Type
7.2.4.4. Analysis by Application Area Type
7.2.4.5. Analysis by End Users

8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodologies

8.4. Company Competitiveness Analysis: Nutraceuticals
8.4.1. Nutraceutical Developers Based in North America (Peer Group 1)
8.4.2. Nutraceuticals Developers Based in Europe (Peer Group 2)
8.4.3. Nutraceuticals Developers Based in Asia-Pacific (Peer Group 3)
8.4.4. Nutraceuticals Developers Based in Middle East and North Africa, and Latin America (Peer Group 4)

8.5. Key Findings

9. COMPANY PROFILES
9.1. Chapter Overview
9.2. Archer Daniels Midland Company
9.2.1. Company Overview
9.2.2. Financial Information
9.2.3. Service / Product Portfolio
9.2.4. Recent Developments and Future Outlook

* Similar detail is presented for other below mentioned companies based on information in the public domain

9.3. Abbott
9.4. Amway
9.5. BASF
9.6. Danone
9.7. Gaia Herbs
9.8. General Mills
9.9. Glanbia
9.10. Herbalife Nutrition
9.11. Jamieson Wellness
9.12. Nestle Health Science
9.13. NOW
9.14. Otsuka Pharmaceuticals
9.15. PepsiCo
9.16. Ritual
9.17. The Kraft Heinz Company
9.18. The Hain Celestial Group
9.19. Yakult Honsha

10. SWOT ANALYSIS

11. MARKET IMPACT ANALYSIS
11.1. Chapter Overview
11.2. Market Drivers
11.3. Market Restraints
11.4. Market Opportunities
11.5. Market Challenges
11.6. Conclusion

12. GLOBAL NUTRACEUTICALS MARKET
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Trends Disruption Impacting Market
12.4. Global Nutraceuticals Market: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

12.5. Multivariate Scenario Analysis
12.5.1. Conservative Scenario
12.5.2. Optimistic Scenario

12.6. Key Market Segmentations

13. MARKET OPPORTUNITIES BASED ON TYPE OF PRODUCT
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Revenue Shift Analysis
13.4. Market Movement Analysis
13.5. Penetration-Growth (P-G) Matrix

13.6. Nutraceuticals Market for Functional Foods: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.6.1. Nutraceuticals Market for Cereal: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.6.2. Nutraceuticals Market for Bakery and Confectionary: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.6.3. Nutraceuticals Market for Dairy: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.6.4. Nutraceuticals Market for Snacks: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.6.5. Nutraceuticals Market for Other Functional Food Types: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

13.7. Nutraceuticals Market for Functional Beverages: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.7.1. Nutraceuticals Market for Energy Drinks: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.7.2. Nutraceuticals Market for Sports Drinks: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.7.3. Nutraceuticals Market for Fortified Juice: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.7.4. Nutraceuticals Market for Dairy and Dairy Alternative Beverage: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.7.5. Nutraceuticals Market for Other Functional Beverages: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

13.8. Nutraceuticals Market for Dietary Supplements: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.8.1. Nutraceuticals Market for Vitamins: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.8.2. Nutraceuticals Market for Minerals: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.8.3. Nutraceuticals Market for Botanicals: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.8.4. Nutraceuticals Market for Enzymes: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.8.5. Nutraceuticals Market for Fatty Acids: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.8.6. Nutraceuticals Market for Proteins: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.8.7. Nutraceuticals Market for Other Dietary Supplements: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

13.9. Data Triangulation and Validation

14. MARKET OPPORTUNITIES BASED ON TYPE OF FORM
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Revenue Shift Analysis
14.4. Market Movement Analysis
14.5. Penetration-Growth (P-G) Matrix
14.6. Nutraceuticals Market for Capsules and Tablets: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.7. Nutraceuticals Market for Liquid: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.8. Nutraceuticals Market for Powder: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.9. Nutraceuticals Market for Other Forms: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.10. Data Triangulation and Validation

15. MARKET OPPORTUNITIES BASED ON TYPE OF INGREDIENT
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Revenue Shift Analysis
15.4. Market Movement Analysis
15.5. Penetration-Growth (P-G) Matrix

15.6. Nutraceuticals Market for Vitamins: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
15.6.1. Nutraceuticals Market for Herbals: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
15.6.2. Nutraceuticals Market for Probiotics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
15.6.3. Nutraceuticals Market for Minerals: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
15.6.4. Nutraceuticals Market for Enzymes and Amino Acids: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
15.6.5. Nutraceuticals Market for Other Applications: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

15.7. Data Triangulation and Validation

16. MARKET OPPORTUNITIES BASED ON APPLICATION AREA
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Revenue Shift Analysis
16.4. Market Movement Analysis
16.5. Penetration-Growth (P-G) Matrix
16.6. Nutraceuticals Market for Immune Health: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.7. Nutraceuticals Market for Heart Health: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.8. Nutraceuticals Market for Bone and Joint Health: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.9. Nutraceuticals Market for Cognitive Health: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.10. Nutraceuticals Market for Diabetes: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.11. Nutraceuticals Market for Digestive / Gut Health: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.12. Nutraceuticals Market for Energy & Endurance: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.13. Nutraceuticals Market for Reproductive Health: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.14. Nutraceuticals Market for Other Applications: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.15. Data Triangulation and Validation

17. MARKET OPPORTUNITIES BASED ON TYPE OF DISTRIBUTION CHANNEL
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Revenue Shift Analysis
17.4. Market Movement Analysis
17.5. Penetration-Growth (P-G) Matrix
17.6. Nutraceuticals Market for Hypermarkets / Supermarkets: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.7. Nutraceuticals Market for Pharmacies / Drug Stores: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.8. Nutraceuticals Market for Specialty Stores: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.9. Nutraceuticals Market for Online Stores: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.10. Nutraceuticals Market for Other Channels: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.11. Data Triangulation and Validation

18. MARKET OPPORTUNITIES FOR NUTRACEUTICALS IN NORTH AMERICA
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Revenue Shift Analysis
18.4. Market Movement Analysis
18.5. Penetration-Growth (P-G) Matrix

18.6. Nutraceuticals Market in North America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.6.1. Nutraceuticals Market in the US: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.6.2. Nutraceuticals Market in Canada: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.6.3. Nutraceuticals Market in Mexico: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

18.7. Data Triangulation and Validation

19. MARKET OPPORTUNITIES FOR NEUTRACEUTICALS IN EUROPE
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Revenue Shift Analysis
19.4. Market Movement Analysis
19.5. Penetration-Growth (P-G) Matrix

19.6. Nutraceuticals Market in Europe: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.1. Nutraceuticals Market in Germany: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.2. Nutraceuticals Market in France: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.3. Nutraceuticals Market in Italy: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.4. Nutraceuticals Market in Spain: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.5. Nutraceuticals Market in the UK: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.6. Nutraceuticals Market in Rest of Europe: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

19.7. Data Triangulation and Validation

20. MARKET OPPORTUNITIES FOR NUTRACEUTICALS IN ASIA-PACIFIC
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Revenue Shift Analysis
20.4. Market Movement Analysis
20.5. Penetration-Growth (P-G) Matrix

20.6. Nutraceuticals Market in Asia-Pacific: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.1. Nutraceuticals Market in China: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.2. Nutraceuticals Market in India: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.3. Nutraceuticals Market in Japan: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.4. Nutraceuticals Market in South Korea: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.5. Nutraceuticals Market in Australia: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.6. Nutraceuticals Market in Russia: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.7. Nutraceuticals Market in Thailand: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.8. Nutraceuticals Market in Malaysia: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.9. Nutraceuticals Market in Indonesia: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.10. Nutraceuticals Market in Rest of the Asia-Pacific: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

20.7. Data Triangulation and Validation

21. MARKET OPPORTUNITIES FOR NUTRACEUTICALS IN MIDDLE EAST AND NORTH AFRICA (MENA)
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Revenue Shift Analysis
21.4. Market Movement Analysis
21.5. Penetration-Growth (P-G) Matrix

21.6. Nutraceuticals Market in Middle East and North Africa (MENA): Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.1. Nutraceuticals Market in Egypt: Historical Trends (Since 2019) and Forecasted Estimates (Till 205)
21.6.2. Nutraceuticals Market in Saudi Arabia: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.3. Nutraceuticals Market in United Arab Emirates (UAE): Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

21.7. Data Triangulation and Validation

22. MARKET OPPORTUNITIES FOR NUTRACEUTICALS IN LATIN AMERICA
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Revenue Shift Analysis
22.4. Market Movement Analysis
22.5. Penetration-Growth (P-G) Matrix

22.6. Nutraceuticals Market in Latin America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.1. Nutraceuticals Market in Argentina: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.2. Nutraceuticals Market in Brazil: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

22.7. Data Triangulation and Validation

23. APPENDIX 1: TABULATED DATA

24. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

25. CUSTOMIZATION OPPORTUNITIES

26. ROOTS SUBSCRIPTION SERVICES

27. AUTHOR DETAIL